A Multi Centre, Double Blind, Placebo-controlled Study to Evaluate the Non Steroidal Anti-inflamatory Drugs (NSAIDS) Sparing Effect of Etanercept in Adult Subjects With Axial Involvement of Spondyloarthritis.
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2015
At a glance
- Drugs Etanercept (Primary)
- Indications Spondylarthritis
- Focus Therapeutic Use
- Acronyms SPARSE
- Sponsors Pfizer
- 15 Nov 2015 Post-hoc analysis results published in The Journal of Rheumatology.
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2013 Planned End Date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.